Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline

NIH Pandemic-Era Grants

Pandemic Era Grants

2024

↗ Live URL (may be dead)

Document text

Principal Investigator: RICHARD  LEIGH
Organization: JOHNS HOPKINS UNIVERSITY
Fiscal Year: 2024
Award: $621,691
Funding agency: National Institute of Neurological Disorders and Stroke

Project Summary/Abstract
This study is focused on expanding our understanding of post-stroke cognitive impairment and
dementia (PSCID). Studies have found that patients who suffer a stroke are at increased risk for
developing subsequent cognitive decline. While this has been demonstrated epidemiologically,
the mechanism by which this occurs is not known. PSCID is a form of vascular cognitive
impairment and dementia (VCID). VCID has been linked to progressive changes in the white
matter, referred to as white matter hyperintensities (WMH), that are readily seen on magnetic
resonance imaging (MRI). It has been hypothesized that disruption of the blood-brain barrier
(BBB) precedes the development of WMH. Thus, imaging the BBB may be a way to determine
who is at risk for developing VCID. It is the central hypothesis of this proposal that PSCID is due
to acceleration of VCID brought on by the acute ischemic event and is characterized by global
disruption of the BBB which precedes the development of WMH. Thus we aim to: 1) Test if BBB
disruption detected on routine clinical MRI scans of the brain is predictive of PSCID, 2) Study
the mechanism of progressive WMH in post-stroke patients using serial research MRI scans to
measure BBB disruption of normal appearing white matter before it progresses to WMH, and 3)
Translate a novel MRI method into the clinical setting that uses arterial spin labeling (ASL) to
measure BBB disruption without the administration of exogenous contrast. To achieve these
objectives patients will be recruited from hospitals in the Johns Hopkins Health System. Patients
will be followed with serial cognitive testing to detect cognitive decline over a 3-year period. BBB
measurements will be extracted from the MRI scans done at the time of the evaluation for acute
stroke. A subset of patients will be followed with serial research MRIs. Research MRIs will be
used to track the progression of NAWM to WMH and its relationship to BBB disruption. These
research MRIs will also implement a novel ASL method for measuring BBB permeability to
determine if this method could be used instead of contrast-based methods. The long-term goal
of this research is to validate a biomarker for the pathogenesis of PSCID such that patients at
risk can be identified for therapeutic trials and potential therapeutics can be screened for their
effect on the pathology.

Terms: <AD related dementia><ADRD><Acceleration><Acute><Affect><Alzheimer's and related dementias><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Amentia><Apoplexy><Arteriosclerotic Dementia><Autoregulation><BBB crossing><BBB disruption><BBB permeabilization><BBB permeable><Biological Markers><Blood><Blood - brain barrier anatomy><Blood Reticuloendothelial System><Blood Tests><Blood flow><Blood-Brain Barrier><Brain><Brain Nervous System><Brain Vascular Accident><Brain scan><Care Givers><Caregivers><Cell Communication and Signaling><Cell Signaling><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Cerebrum><Chronic><Clinical><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive function abnormal><Contrast Agent><Contrast Drugs><Contrast Media><Dementia><Development><Disease><Disorder><Disturbance in cognition><Dysfunction><Encephalon><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology><Epidemiology Research><Evaluation><Event><Functional disorder><Gadolinium><Gd element><Goals><Health Care Systems><Health system><Healthcare Systems><Hemato-Encephalic Barrier><Hematologic Tests><Hematological Tests><Hematology Testing><Homeostasis><Hospitals><Hydrogen Oxide><Hypoxia><Hypoxic><Image><Impaired cognition><Impairment><Incidence><Individual><Inflammatory><Inflammatory Response><Injury><Intracellular Communication and Signaling><Ischemia><Ischemic Stroke><Link><Longitudinal Studies><MR Imaging><MR Tomography><MRI><MRI Scans><MRIs><Magnetic Resonance Imaging><Magnetic Resonance Imaging Scan><Maps><Measurement><Measures><Mediating><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Methods><Microvascular Dysfunction><Monitor><NMR Imaging><NMR Tomography><Nuclear Magnetic Resonance Imaging><Oxygen Deficiency><Pathogenesis><Pathology><Patients><Perfusion><Permeability><Persons><Physiological Homeostasis><Physiopathology><Prevalence><Process><Public Health><Radiopaque Media><Research><Resolution><Risk><Role><Secondary Prevention><Serial Magnetic Resonance Imaging><Signal Transduction><Signal Transduction Systems><Signaling><Societies><Sterility><Stroke><Techniques><Testing><Therapeutic><Therapeutic Trials><Time><Translating><Vascular Dementia><Vascular Diseases><Vascular Disorder><Water><White Matter Hyperintensity><Zeugmatography><acute cerebrovascular accident><acute stroke><after stroke><aged group><aged groups><aged individual><aged individuals><aged people><aged person><aged persons><aged population><aged populations><aging population><arterial spin labeling><arterial spin tagging><bio-markers><biologic marker><biological signal transduction><biomarker><biomarker development><blood vessel disorder><blood-brain barrier crossing><blood-brain barrier disruption><blood-brain barrier permeabilization><blood-brain barrier permeable><bloodbrain barrier><bloodbrain barrier crossing><bloodbrain barrier disruption><bloodbrain barrier permeabilization><bloodbrain barrier permeable><brain attack><brain tissue><cardiac disease induced cognitive impairment><cardiovascular risk><cardiovascular risk factor><cerebral><cerebral vascular accident><cerebrovascular accident><clinical imaging><cognitive assessment><cognitive decline after stroke><cognitive decline in stroke><cognitive dysfunction><cognitive dysfunction after stroke><cognitive dysfunction in stroke><cognitive impairment after stroke><cognitive impairment in stroke><cognitive loss><cognitive testing><cohort><developmental><epidemiologic><epidemiologic investigation><epidemiological><epidemiology study><imaging><imaging study><improved><injuries><injury to tissue><long-term study><longitudinal imaging><longitudinal outcome studies><longterm study><microvascular complications><microvascular disease><new marker><novel><novel biomarker><novel marker><pathophysiology><patient subclass><patient subcluster><patient subgroups><patient subpopulations><patient subsets><patient subtypes><perfusion imaging><population aging><post stroke><post stroke cognitive decline><post stroke cognitive dysfunction><post stroke cognitive impairment><poststroke><poststroke cognitive decline><poststroke cognitive dysfunction><poststroke cognitive impairment><predictive biomarkers><predictive marker><predictive molecular biomarker><recruit><recurrence prevention><resolutions><response><serial MRI><serial imaging><small vessel disease><social role><sterile><stroke patient><stroked><strokes><substantia alba><targeted biomarker><time use><tissue injury><vascular cognitive impairment and dementia><vascular component><vascular contributions to cognition/dementia><vascular contributions to cognitive impairment and dementia><vascular contributions to dementia><vascular dysfunction><vascular factor><vascular risk factor><vasculopathy><white matter>